| Dr Holley Galland, MD,MPH | |
|
4615 Government St Bldg 2, Baton Rouge, LA 70806-5820 | |
| (225) 922-0445 | |
| (225) 922-0771 |
| Full Name | Dr Holley Galland |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 4615 Government St Bldg 2, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508926429 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 13389 (Louisiana) | Primary |
| 207QA0000X | Family Medicine - Adolescent Medicine | 13389 (Louisiana) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Holley Galland, MD,MPH 4615 Government St Bldg 2, Baton Rouge, LA 70806-5820 Ph: (225) 922-0445 | Dr Holley Galland, MD,MPH 4615 Government St Bldg 2, Baton Rouge, LA 70806-5820 Ph: (225) 922-0445 |
News Archive
Orexo today announced that it has received approval from the U.S. Food and Drug Administration for Zubsolv (buprenorphine/naloxone) sublingual tablet CIII.
There is strong evidence that expanding health insurance increases access to care, improves health in a variety of ways, and reduces mortality, according to Harvard T.H. Chan School of Public Health researchers who analyzed a decade's worth of evidence on the effects of insurance coverage on health.
Neuroscience research at the University of Sheffield has been recognized by Her Majesty The Queen for delivering real benefits in improving patient outcomes for people living with some of the most devastating neurodegenerative diseases.
A new screening technique for methicillin-resistant Staphylococcus aureus (MRSA) cuts by 75% the time taken to identify patients carrying MRSA and could be used to help prevent transmission of the bacteria in hospitals.
Isis Pharmaceuticals, Inc. announced today that follow-up preliminary data from a single dose, open-label Phase 1 study of ISIS-SMNRx in children with spinal muscular atrophy, show that most SMA children receiving the two highest doses of the drug (6 mg and 9 mg) continued to show improvements in muscle function tests up to 14 months after a single injection of the drug.
› Verified 4 days ago
Dr. Roderick A. Hart Sr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3801 North Blvd, Baton Rouge, LA 70806 Phone: 601-454-9462 | |
Dr. Brent Oliver Campanella, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5131 Essen Ln, Baton Rouge, LA 70809 Phone: 225-769-0043 Fax: 225-769-0133 | |
Robert Dwight Brower, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7037 Woodstock Dr, Baton Rouge, LA 70809 Phone: 225-975-8680 | |
Kristin Wemple Morvant, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 16777 Medical Center, Baton Rouge, LA 70816 Phone: 225-754-3278 | |
Dr. Tamika Session Mayo, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3401 North Blvd, Ste 360, Baton Rouge, LA 70806 Phone: 225-381-2712 Fax: 225-381-2715 | |
Gregory F Ferrara, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13828 Coursey Blvd, Baton Rouge, LA 70817 Phone: 225-751-1544 Fax: 225-751-1909 | |
James Michael Robinson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7566 Picardy Ave, Baton Rouge, LA 70808 Phone: 225-765-5500 Fax: 225-256-1400 |